Browsing byAuthorConduit, C
Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
2022-01 | GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol) | Conduit, C; Mak, B; Qu, W; Di Lulio, J; Burder, R; Bressel, M; Cusick, T; Dhillon, HM; De Abreu Lourenço, R; Underhill, C; Torres, J; Crumbaker, M; Honeyball, F; Linton, A; Allen, R; Davis, ID; Clark, SJ |
2023-08-21 | The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy. | Roberts, MJ; Conduit, C; Davis, ID; Effeney, RM; Williams, S; Martin, JM; Hofman, MS; Hruby, G; Eapen, R; Gianacas, C; Papa, N; Lourenço, RDA; Dhillon, HM; Allen, R; Fontela, A; Kaur, B; Emmett, L; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), |
2023-02-20 | Trial in progress: PRESTIGE—Primary retroperitoneal lymph node dissection (RPLND) for clinical stage II (CSII) testicular germ cell tumour (TGCT) and its impact on health-related quality of life (HRQoL) compared to chemotherapy or radiotherapy. | Conduit, C; Lewin, JH; Liow, ECH; Dhillon, HM; Hong, W; De Abreu Lourenço, R; Lawrentschuk, N; Thomas, B; Grimison, PS; Ahmadi, N; Sengupta, S; Tran, B |